The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
Condition: Antiphospholipid Syndrome Intervention: Drug: Belimumab Sponsor: University of Turin, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2021 Category: Research Source Type: clinical trials